Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

NVNO holding history

enVVeno Medical Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVNO overviewAll 13F holders of NVNOFull Q2 2026 holdings

Shares (Q2 2026)
1
Value
$11
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVNO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261$11<0.1%−242−99.6%ReducedHolders
Q1 2026243$2.46K<0.1%−675−73.5%ReducedConverted for a 1-for-35 splitHolders
Q4 202532,121$10.3K<0.1%+21,851+212.8%AddedHolders
Q3 202510,270$9.30K<0.1%+4,210+69.5%AddedHolders
Q2 20256,060$24.2K<0.1%−4,711−43.7%ReducedHolders
Q1 202510,771$28.3K<0.1%+4,711+77.7%AddedHolders
Q4 20246,060$18.3K<0.1%−10,566−63.6%ReducedHolders
Q3 202416,626$55.9K<0.1%−174−1.0%ReducedHolders
Q2 202416,800$88.2K<0.1%+11,242+202.3%AddedHolders
Q1 20245,558$30.2K<0.1%+5,557+555,700.0%AddedHolders
Q4 20231$5<0.1%00.0%UnchangedHolders
Q3 20231$5<0.1%−670−99.9%ReducedHolders
Q2 2023671$2.07K<0.1%−2,813−80.7%ReducedHolders
Q1 20233,484$16.3K<0.1%+3,483+348,300.0%AddedHolders
Q4 20221$5<0.1%−1,673−99.9%ReducedHolders
Q3 20221,674$11.0K<0.1%+1,410+534.1%AddedHolders
Q2 2022264$1.00K<0.1%−297−52.9%ReducedHolders
Q1 2022561$4.00K<0.1%−2,022−78.3%ReducedHolders
Q4 20212,583$17.0K<0.1%+2,582+258,200.0%AddedHolders
Q3 20211$00.0%−7,584−100.0%ReducedHolders
Q2 20217,585$52.0K<0.1%−9,476−55.5%ReducedHolders
Q1 202117,061$114.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.